Home News Drug Discovery & Development

Drug Discovery & Development

Nifty Pharma index in the red; Cipla, Lupin top drags 

New Delhi, November 27, 2017: Pharma stocks CiplaBSE -0.46 % (down 1.70 per cent), GlaxoSmithKline PharmaceuticalsBSE -0.79 % (down 0.92 per cent) and LupinBSE 0.30 % (down 0.42 per cent) were trading down in afternoon trade on Monday, dragging the...

Venus Remedies ties up with Israel’s Teva for anti-cancer drug

Chandigarh, August 27, 2014 -  Pharma major Venus Remedies today said it has entered into a collaborative agreement with Israel-based generic drug maker Teva for selling an anti- cancer drug in the Canadian market. Under this collaboration, Venus Remedies will be initially manufacturing the...

Cipla bets big on cell therapy

Mumbai , March 22,2014 - Stem cells are set to be a major branch of medical treatment, says Cipla Chairman YK Hamied. Regenerative medicine, or cell therapy, is a rapidly emerging area of biomedical research and would be...

Drug Discovery Unit (DDU), University of Dundee Licenses GVK BIO Online SAR Database (GOSTAR)

Hyderabad, Andhra Pradesh, India, Wednesday, April 10, 2013 -- (Business Wire India) -- GVK Biosciences (GVK BIO) today announced that it has licensed its Online SAR Database - GOSTAR to the Drug Discovery Unit (DDU) at the University of Dundee. GOSTAR, a manually curated database, has been developed over the span of a decade by a team comprising of more than 200 curators. The product issued globally in various areas such as pharmaceuticals, academics, government sectors, apart from numerous publications that cite the data contained in GOSTAR. GOSTAR contains over 6 million compounds manually curated through the screening of over 2 million patents and 400,000 journals and it also contains more than 18 million quantitative SAR points.

AstraZeneca to shut R&D centre in Bangalore

168 research jobs at stake; had during 2012 shed some R&D jobsBangalore January 31, 2014: AstraZeneca, the global pharmaceutical major,  said that it will close its research and development site in Bangalore later this year.  The ‘Avishkar R&D Site’,...

Venus Remedies gets Swiss nod to market oncology drug

Chandigarh, august 21, 2014 - Pharma major Venus Remedies has secured its first marketing authorisation in Switzerland from Swiss drug authority ‘Swissmedic’ for its oncology drug ’Gemcitabine’ The marketing approval for Gemcitabine will help the company further strengthen its oncology...

Developments in Bio-informatics will help drive discoveries

    • Training,  revamp  of  University  system,  Promote  Translation  of  Academicre search, Promoting Bio-Entrepreneurship will accelerate the industry growth

 

  • Synthetic  Biotechnology  has  tremendous  potential,  affordable  gene  sequencing can play a major role in the Food, Energy, fragrance & Flavors

Baxter Advances Clinical Practice of Intravenous (IV) Therapy with Launch of Plasma-Lyte A...

  Bangalore, December, 06’2013 - Baxter India Pvt. Ltd. (MD Anish Bafna, www.baxter.in) a subsidiary of global healthcare company, Baxter International Inc. (NYSE:BAX), announced the launch of Plasma-Lyte A (pH 7.4), a physiologically balanced crystalloid solution, having similar electrolyte...

‘New drug for Alzheimer’s, Parkinson’s in the pipeline’

New Delhi December 28, 2013: The Government’s drug price control order may have impacted drug-makers’ profitability, but Chennai-based Arvind Remedies Ltd is unfazed. A new drug to combat Alzheimer’s and Parkinson’s diseases is in the pipeline, says B. Arvind...

Cipla inks third respiratory deal in less than a week

In pact with Biopharm to set up company in Algeria Mumbai, Feb 17, 2015 : Drugmaker Cipla has inked its third deal in less than a week, all aimed at beefing up its capacity in the respiratory products segment. On Friday, Cipla...